PDCD1LG2 and neoplasm: Additionally, according to an analysis of the molecular profiling of circulating tumor cells (CTCs) and clinical factors in HNSCC, it was found that the expression of PDCD1LG2 as PD-1 ligand genes was related to poor prognosis of HNSCC [45].